What is our mission? Building ventures, advancing health!

Regardless of their relevance or brilliance, 95% of all healthtech inventions never reach the market. All of these innovations can significantly advance lives worldwide.

 

Bert-Arjan Millenaar, CEO and founder of NLC, went through this first-hand. His experience proves why NLC is an essential company that significantly impacts society every day.

In May 2014, Bert-Arjan became the proud father of a little girl. Unfortunately, she was born prematurely, leaving him helpless next to her incubator. He desperately wanted nothing more than to hold his little girl and bring her home. At the time, Bert-Arjan didn’t know that a professor across the country was working on an invention that could have prevented his pain. A lack of entrepreneurship and network kept the professors’ innovation (Concord Neonatal – hyperlink) out of our healthcare system. Unfortunately, this is just one of many stories with the same plot: a patient is in critical need of equipment that has not yet been brought to the market.

We at NLC have made it our mission to change this.

We find inventions, select the most promising ones, and build them into viable healthtech ventures to advance health.

Since 2015, NLC has evaluated thousands of inventions and built over 80 ventures. We have a great team of dedicated employees and industry experts (+3000 individuals) who enable us to continue our mission daily. We guarantee that you are in safe, trustworthy hands!

Together we are building ventures and advancing health for patients worldwide.

How do we achieve success? Through Entrepreneurship at Scale!

We strongly believe that the most successful way to bring more healthtech inventions to patients is by using entrepreneurship at scale. Entrepreneurship is essential to get a venture through the early stages, and this is where you need to put in the hard work on many levels simultaneously. The dedication of the CEOs and their team is crucial to getting the venture to the market successfully.

By building ventures at scale, we can benefit from the data and learnings we’ve harvested along the way. We know the pitfalls. We know the shortcuts. We try hard, and if we fail, we fail fast. To support a venture, we build teams around it that know what it takes to make a venture successful. We surround our CEOs with expertise and support in all areas, from helping to secure finance, providing advice on patents and certifications, training the team on sales, and everything in between.

Bringing an invention to the market is a complex process with no guarantee for success, but working with NLC made sure my invention got on the right track!”

Associate Professor DDr Winkler
Associate Professor and inventor of Artifex

Go to venture

Our Network

Our network is essential to us and plays a crucial role in our journey to success. Committed specialists worldwide support our team through our venture-building process. 

We partner with 4 groups of people, and together we strive for success!

  1. Inventors and research institutes that want to bring their inventions to the market with us,
  2. Medical, technical and business specialists that help us evaluate the inventions, 
  3. Investors that are willing to take the risk and invest in early seed start-ups,
  4. Entrepreneurs and advisors that help us grow the ventures we have built.

Together, we overcome fragmentation so we can build ventures and advance health.

How do we help you lower your risk curve?

NLC operates at the beginning of the risk curve, where the risk is high, and the invested capital is relatively low. This opens the opportunity for us to make an impact by utilising our entrepreneurship at scale to lower the risk curve of our ventures. Our ventures are de-risked at a faster rate with low(er) costs, which scales NLC’s portfolio further (statistically) and de-risks our model.

This means fewer risks and more rewards!

I have been working with NLC for a couple of years. From the first moment, NLC saw opportunities where I didn’t. Without the expertise and commitment of NLC, Nico.lab simply wouldn’t exist and we wouldn’t be able to help stroke patients this day.”

Merel Boers
Cofounder and Chief Research Officer at Nico.lab

Go to venture

Sustainable Development Goals

The 17 Sustainable Development Goals (SDGs) were set up in 2015 by United Nations and are intended to be achieved by 2030. The interlinked global goals provide a shared blueprint for peace and prosperity for people and the planet, now and into the future.

All our decisions at NLC are made with the aim to make a positive impact on people and our planet. We do this every day when building ventures to advance health.

What does it mean to be a certified B Corporation?

NLC is especially proud to be a Certified B Corporation since 2020. B Lab, a non-profit company, established that we meet their strict social and environmental performance standards, accountability, and transparency.

Every day, NLC is dedicated to advancing health and making it accessible in a sustainable way. Therefore, the standards to qualify as a B Corp match the NLC’s DNA perfectly. Our team of employees, extensive network of specialists, and our way of working are built around bringing together the best tech with the best people.

Together, we build ventures that can have huge impacts on the health of individuals worldwide.